TDB backs Visakhapatnam start-up's AI-assisted cervical cancer screening device 'GrivaVision'
The Technology Development Board signed an agreement on 10 August 2026 to support Griva Healthcare, Visakhapatnam, in manufacturing 'GrivaVision', an indigenous portable AI-assisted digital colposcope for cervical cancer screening.
Summary
The Technology Development Board (TDB) of the Department of Science and Technology signed an agreement with Griva Healthcare Pvt. Ltd., Visakhapatnam, on 10 August 2026 to support manufacturing and commercialisation of 'GrivaVision'. GrivaVision is an indigenously developed, portable digital colposcope with AI-assisted capabilities for early detection of cervical pre-cancerous lesions. With TDB's support, the company will set up manufacturing at Kollam, Kerala, to make screening more accessible in primary and community health settings.
Key facts
- Funder
- Technology Development Board, DST
- Company
- Griva Healthcare Pvt. Ltd., Visakhapatnam
- Product
- GrivaVision – portable AI-assisted digital colposcope
- Use
- Early detection of cervical pre-cancerous lesions
- Manufacturing site
- Kollam, Kerala
Practice MCQs 1 questions
'GrivaVision', supported by the Technology Development Board in August 2026, is an AI-assisted device for screening which disease?
Show answer
Correct answer: D — Cervical cancer
GrivaVision is a portable AI-assisted digital colposcope for early detection of cervical pre-cancerous lesions; it will be made at Kollam, Kerala.